Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration

Cytokine. 2008 Aug;43(2):103-4. doi: 10.1016/j.cyto.2008.05.010. Epub 2008 Jun 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use*
  • Female
  • Humans
  • Interleukin-17 / blood*
  • Jaw Diseases / chemically induced*
  • Male
  • Middle Aged
  • Multiple Myeloma / blood*
  • Multiple Myeloma / drug therapy*
  • Osteonecrosis / chemically induced*

Substances

  • Diphosphonates
  • Interleukin-17